Inhibrx Biosciences (INBX) Prepaid Assets (2023 - 2025)

Inhibrx Biosciences' (INBX) quarterly Prepaid Assets came in at $8.4 million in Q4 2025, up 2108.12% year-on-year from $382000.0 in Q4 2024, and up 1957.32% on a QoQ basis from $410000.0 in Q3 2025.

Inhibrx Biosciences (INBX) Prepaid Assets (2023 - 2025) Analysis & Trends

Inhibrx Biosciences (INBX) has 3 years of Prepaid Assets data on file, last reported at $8.4 million in Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 2108.12% year-over-year to $8.4 million in Q4 2025; TTM through Dec 2025 was $8.4 million, a 2108.12% increase from a year earlier, with the FY2025 full-year figure at $8.4 million, up 2108.12% from the prior year.
  • Prepaid Assets for Q4 2025 stood at $8.4 million, up from $410000.0 in the prior quarter.
  • Over the last five years, Prepaid Assets for INBX reached as high as $8.4 million in Q4 2025 and fell as low as $269000.0 in Q1 2025.
  • Historically, Prepaid Assets has averaged $1.5 million across 3 years, with a median of $396000.0 in 2024.
  • On a YoY basis, Prepaid Assets climbed as much as 2108.12% in 2025 and fell as far as 70.7% in 2025.
  • Year by year, Prepaid Assets stood at $366000.0 in 2023, then increased by 4.37% to $382000.0 in 2024, then surged by 2108.12% to $8.4 million in 2025.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $8.4 million in Q4 2025, $410000.0 in Q3 2025, and $283000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Inhibrx Biosciences 1.32 Bn 1.32 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 8.44 Mn
Sep 30, 2025 410,000.00
Jun 30, 2025 283,000.00
Mar 31, 2025 269,000.00
Dec 31, 2024 382,000.00
Sep 30, 2024 748,000.00
Jun 30, 2024 966,000.00
Dec 31, 2023 366,000.00